Morgan RL, et al. - Since statistically significant racial differences associated with lung cancer treatment and outcomes have been shown in previous research, therefore, researchers assessed disparities in initial imaging as well as survival between Blacks, Hispanics and non-Hispanic Whites in this study utilizing the linked Surveillance, Epidemiology, and End Results–Medicare database between 2007 and 2015. This analysis involved 28,881 non-Hispanic Whites, 3,123 Black, and 1,907 Hispanics. The participants aged ≥ 66 years and were enrolled in Medicare fee-for-service and had received a diagnosis of lung cancer. Between groups, PET/CT utilization was compared as the primary outcome. Twelve-month cancer specific survival was assessed as a secondary outcome. Improved survival was observed in relation to PET/CT. A less chance of undergoing guideline recommended PET/CT imaging at diagnosis of lung cancer was observed among Blacks and Hispanics, which may, in part, explain disparities in survival.